01563nas a2200265   4500000000100000008004100001260001600042653001000058653003000068653001100098653001100109653002300120653002400143653000900167100002300176700001200199700002000211700001500231245004300246856007200289300000700361490000700368520090800375022001401283       2011                            d  c2011 Jan 1510aChild10aDrug Therapy, Combination10aFemale10aHumans10aLeprostatic Agents10aLeprosy, Borderline10aSkin1 aDi Martino Ortiz B1 aMasi MR1 aKnopfelmacher O1 aLezcano LB00a[Childhood leprosy: Report of a case].  uhttp://dermatology.cdlib.org/1701/8_vignette/13_10-00171/ortiz.html  a130 v173 a<p>Childhood leprosy is very common, especially in tropical and subtropical areas, such as Paraguay. Early symptoms can be missed in a routine examination and the diagnosis can pass unnoticed. Pediatricians and dermatologists should remember the manifestations of this disease in order to make an early diagnosis. We present the case of a 10-year-old child with borderline Hansen disease, considered unusual in children. She was treated with multibacillary therapy (MB-WHO) with the combination of Rifampicin 600 mg, clofazimine 300 mg, and dapsone 100 mg once a month (the three drugs together on the same day once a month for 18 months); the remaining 28 days of the month, the child received clofazimine 50 mg/day and dapsone 100 mg/day (the two drugs together on the same day 28 days of the month for 18 months). This therapy produced complete remission of the lesions without reactional states.</p>  a1087-2108